Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion
Launched by ASSIUT UNIVERSITY · Mar 10, 2016
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion criteria:
- • 1. Women not taken analgesics or anxiolytics in the 24 hours prior insertion
- • 2. Women not taken misoprostol prior to IUD insertion
- • 3. No contraindication to or history of allergic reaction to lidocaine or NO donors.
- • 4. Women who will accept to participate in the study
- Exclusion criteria:
- • 1. Lidocaine allergy
- • 2. History of migraine or chronic headache
- • 3. Any contraindication to IUD placement
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Cairo, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials